Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR. [NA]

View source ↗

Summary

A clinical study evaluating the GeminiOne TEER System for treating severe, symptomatic mitral regurgitation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GeminiOne TEER System

Snippet

Sponsor: Sierra Valve LLC | Conditions: Mitral Regurgitation | NA | Status: RECRUITING